Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT04926194 ·Status: COMPLETED ·Phase: PHASE2

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

NCT00562497 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Steroid Resistant GVHD by Infusion MSC

NCT00827398 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

NCT00284986 ·Status: COMPLETED ·Phase: PHASE2

Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD)

NCT01764100 ·Status: UNKNOWN ·Phase: PHASE1

Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)

NCT00826046 ·Status: NO_LONGER_AVAILABLE

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

NCT01020539 ·Status: COMPLETED ·Phase: PHASE1

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

NCT04628338 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment

NCT00749164 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

NCT00253552 ·Status: TERMINATED ·Phase: NA

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

NCT00005984 ·Status: TERMINATED ·Phase: PHASE2

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

NCT02724904 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

NCT02061800 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

NCT00548717 ·Status: TERMINATED ·Phase: PHASE2

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

NCT00603330 ·Status: RECRUITING ·Phase: PHASE2

Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation

NCT01941394 ·Status: UNKNOWN ·Phase: PHASE2

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

NCT00759018 ·Status: NO_LONGER_AVAILABLE

Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

NCT00113646 ·Status: TERMINATED ·Phase: PHASE2

Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma

NCT02447055 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00016419 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS

NCT00520468 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

NCT00447460 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Allo HSCT Using RIC for Hematological Diseases

NCT02661035 ·Status: COMPLETED ·Phase: PHASE2